M. Walport

发表

Tierversuche in der Max-Planck-Gesellschaft. Animal Research in the Max Planck Society

W. Singer, S. Treue, D. Tautz, 2016 .

Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide release

Jonathan Cohen, P. Lehner, J. Cohen, 1992, The Lancet.

Clearance of 131I-labeled murine monoclonal antibody from patients' blood by intravenous human anti-murine immunoglobulin antibody.

M. Ritter, A. Epenetos, J. Stewart, 1990, Cancer research.

A study of in vivo immune complex formation and clearance in man.

M. Walport, A. Epenetos, K. Davies, 1990, Journal of immunology.

The organization of the human complement factor I gene (IF): a member of the serine protease gene family.

M. Walport, T. Vyse, G. Bates, 1994, Genomics.

Homozygous hereditary C1q deficiency and systemic lupus erythematosus. A new family and the molecular basis of C1q deficiency in three families.

M. Walport, G. Pearce, A. Vaishnaw, 1996, Arthritis and rheumatism.

Hereditary C1q deficiency and systemic lupus erythematosus.

M. Walport, P. Bowness, L. Borysiewicz, 1994, QJM : monthly journal of the Association of Physicians.

Hereditary complement factor I deficiency.

M. Walport, T. Vyse, K. Davies, 1994, QJM : monthly journal of the Association of Physicians.

Complement Deficiency and Autoimmunity a

M. Botto, M. Walport, B. J. Morley, 1997, Annals of the New York Academy of Sciences.

Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria.

M. Walport, B. Morgan, B. Morgan, 2001, Blood.

Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders

A. Weetman, M. Walport, S. Loizou, 1992, Clinical and experimental immunology.

Autoantibodies to the collagenous region of C1q occur in three strains of lupus‐prone mice

M. Walport, B. J. Morley, P. Trinder, 1996, Clinical and experimental immunology.

Heterogeneity of binding reactivity to different phospholipids of antibodies from patients with systemic lupus erythematosus (SLE) and with syphilis

M. Walport, C. Mackworth-Young, S. Loizou, 1990, Clinical and experimental immunology.

Identification of thiopurine methyltransferase (TPMT) polymorphisms cannot predict myelosuppression in systemic lupus erythematosus patients taking azathioprine.

M. Walport, M. Naughton, M. Botto, 1999, Rheumatology.

Complete heart block and severe aortic incompetence in relapsing polychondritis: clinicopathologic findings.

M. Walport, P. Bowness, T. Morris, 1991, Arthritis and rheumatism.

Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes.

J. Hughes, M. Walport, R. Bernstein, 1990, The Quarterly journal of medicine.

Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.

M. Walport, P. Lachmann, B. Myones, 1985, Journal of immunology.

Multiple lupus susceptibility loci map to chromosome 1 in BXSB mice.

M. Walport, P. Chandler, K. Davies, 1998, Journal of immunology.

The anti‐lipid A antibody HA‐IA binds to rough Gram‐negative bacteria, fixes complement and facilitates binding to erythrocyte CRl (CD35)

M. Walport, J. Cohen, K. Davies, 1993, Clinical and experimental immunology.

Combinations of low concentrations of cytokines and acute agonists synergize in increasing the permeability of endothelial monolayers

R. Haroutunian, H. Beynon, D. Haskard, 1993, Clinical and experimental immunology.

The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms.

M. Walport, J. Schifferli, Y. Ng, 1988, Journal of immunology.

Biosynthesis and secretion of complement component (C3) by activated human polymorphonuclear leukocytes.

M. Walport, M. Botto, C. Sorio, 1992, Journal of immunology.

A rare mediastinal tumour presenting with systemic effects due to IL‐6 and tumour necrosis factor (TNF) production

A. Cope, T. Krausz, J. Schofield, 1995, Clinical and experimental immunology.

Detection of cross-reactive anti-DNA antibody idiotypes in the serum of systemic lupus erythematosus patients and of their relatives.

A. Todd-Pokropek, D. Isenberg, M. Walport, 1985, Arthritis and rheumatism.

Serum sickness and acute renal failure after streptokinase therapy for myocardial infarction

C. Winearls, A. Rees, K. Davies, 1990, Clinical and experimental immunology.

Overrepresentation of the Fcgamma receptor type IIA R131/R131 genotype in caucasoid systemic lupus erythematosus patients with autoantibodies to C1q and glomerulonephritis.

C. Gordon, D. Isenberg, M. Walport, 1999, Arthritis and rheumatism.

Antibody‐mediated glomerulonephritis in mice: the role of endotoxin, complement and genetic background

M. Robson, H. Cook, C. Pusey, 2003, Clinical and experimental immunology.

Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.

M. Walport, J. Schifferli, Y. Ng, 1988, Clinical and experimental immunology.

Extrahepatic secreted complement C3 contributes to circulating C3 levels in humans.

G. Alexander, M. Walport, J. Goldman, 1996, Journal of immunology.

Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseases.

M. Walport, P. Lachmann, M. Walport, 1988, Arthritis and rheumatism.

Erythrocytes transfused into patients with SLE and haemolytic anaemia lose complement receptor type 1 from their cell surface.

M. Walport, P. Lachmann, Y. Ng, 1987, Clinical and experimental immunology.

Pregnancy and antibodies to phospholipids.

M. Walport, M. Walport, 1989, Annals of the rheumatic diseases.

FcγRIIa polymorphism in systemic lupus erythematosus (SLE): no association with disease

D. Isenberg, M. Walport, H. Beynon, 1996 .

C3 nephritic factor and SLE: report of four cases and review of the literature.

D. Isenberg, M. Walport, M. Naughton, 1994, QJM : monthly journal of the Association of Physicians.

Hypereosinophilic syndromes: association with vasculitis, fibrosis and autoimmunity

M. Walport, F. Hall, 1993 .